Table 2.
Author | Participants | Protocol | Outcome |
---|---|---|---|
Cohen et al. 1996 [362] | Endurance trained competitive road racers (male = 5; female = 2) |
• Placebo • 5 mg/kg caffeine • 9 mg/kg caffeine |
⬌ Running performance |
Del Coso et al. 2008 [363] | Endurance trained male cyclists (n = 7) |
• No fluid • Water • 6%CHO Solution • No fluid + 6 mg/kg caffeine capsule • Water + 6 mg/kg caffeine capsule • 6%CHO solution + 6 mg/kg caffeine capsule |
⬌ Maximal voluntary contraction in heat *↑ Maximal cycling power in heat *↑ Maximal leg force via voluntary activation ONLY in water + caffeine and 6%CHO + caffeine |
Cheuvront et al. 2009 [364] | Healthy males (n = 10) |
• 9.0 mg/kg caffeine • Placebo |
⬌ TT performance ⬌ RPE |
Ganio et al. 2011 [365] | Male cyclists (n = 11) |
• Participants consumed either 3 mg/kg caffeine or placebo 60 min prior to and after 45 min of the following trials (4 trials total; total 6 mg/kg): • Warm environment (33 °C): 90 min cycling followed by 15 min performance trial • Cool environment (12 °C): 90 min cycling followed by 15 min performance trial |
Caffeine *↑ increased performance versus placebo independent of temperature |
Roelands et al. 2011 [265] | Trained male cyclists or triathletes (n = 8) |
• 6 mg/kg caffeine • Placebo |
⬌ Acute cycling TT performance |
Pitchford et al. 2014 [366] | Well-trained males (n = 9) |
• 3 mg/kg caffeine • Placebo |
⬌cycling TT performance in heat |
Suvi et al. 2017 [359] | Healthy males (n = 13) and females (n = 10) |
• 6 mg/kg caffeine • Placebo |
⬌ Time to walking exhaustion |
Beaumont et al. 2017 [310, 367] | Recreationally active males (n = 8) |
• 6 mg/kg caffeine • Placebo |
*↑ Endurance cycle performance in heat *↓ RPE during initial 60 min of exercise |
Outcomes are bold caffeine group specific; * = significant difference, ⬌ = no change, ↑ = improved performance, TT = time trial, mg/kg = milligram per kilogram, CHO = carbohydrate, min = minutes, RPE = rating of perceived exertion